Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole-Reference-Cited by-同舟云学术

Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole

Published:2018-06-19 Issue:9 Volume:84 Page:1980-1988
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Vreugdenhil Bas¹,van der Velden Walter J. F. M.¹²,Feuth Ton³,Kox Matthijs⁴,Pickkers Peter⁴,van de Veerdonk Frank L.²⁵,Blijlevens Nicole M. A.¹²,Brüggemann Roger J. M.⁶²^ORCID

Affiliation:

1. Department of Hematology; Radboud University Medical Center; Nijmegen The Netherlands

2. Radboud Institute of Health Sciences and Radboud Center for Infectious Diseases (RCI); Nijmegen The Netherlands

3. Department for Health Evidence; Radboud University Medical Center; Nijmegen The Netherlands

4. Department of Intensive Care Medicine, Radboud Institute for Molecular Life Sciences; Radboud Center for Infectious Diseases (RCI); Nijmegen The Netherlands

5. Department of Infectious Diseases, Radboud Institute for Molecular Life Sciences; Radboud University Medical Center; Nijmegen The Netherlands

6. Department of Pharmacy; Radboud University Medical Center; Nijmegen The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13627/fullpdf

Reference35 articles.

1. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group;Herbrecht;Clin Infect Dis,2015

2. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing;Dolton;J Antimicrob Chemother,2014

3. Voriconazole pharmacokinetics and exposure-response relationships: assessing the links between exposure, efficacy and toxicity;Dolton;Int J Antimicrob Agents,2014